Long Non-Coding RNA Expression in Alpha-1 Antitrypsin Deficient Monocytes Pre- and Post-AAT Augmentation Therapy

Area of Science:

• Molecular Biology
• Genetics
• RNA Biology

Background:

• Long non-coding RNAs (lncRNAs) are crucial regulators of gene expression.
• The role of lncRNAs in alpha-1 antitrypsin (AAT) deficiency remains unexplored.
• AAT augmentation therapy is a standard treatment for AAT deficiency, known to affect microRNA expression.

Purpose of the Study:

• To investigate the impact of AAT augmentation therapy on the lncRNA expression profile in monocytes from individuals with AAT deficiency.
• To identify specific lncRNAs that are differentially expressed following AAT treatment.

Main Methods:

• Mononuclear cells were isolated from AAT-deficient (ZZ) individuals before and after AAT augmentation therapy.
• lncRNA expression profiling was performed using Arraystar lncRNA microarray.
• Differential expression analysis was conducted to identify significant changes in lncRNA levels.

Main Results:

• A total of 17,761 lncRNAs were detected across all samples.
• AAT augmentation therapy resulted in differential expression of 7509 lncRNAs (3084 increased, 4425 decreased, fold change ≥ 2).
• Ex vivo treatment of ZZ monocytes with AAT mimicked many of the observed lncRNA expression changes.

Conclusions:

• AAT augmentation therapy profoundly impacts the lncRNA expression landscape in monocytes of AAT-deficient individuals.
• The observed alterations in lncRNA expression may contribute to the therapeutic effects of AAT augmentation.
• This study highlights lncRNAs as potential novel targets for understanding and treating AAT deficiency.